Enhancement of an Auto-Injector Device for Self-Administration of Etanercept in Patients With Rheumatoid Arthritis Confers Emotional and Functional Benefits.

Autor: Rekaya N; Pfizer, Walton Oaks, Surrey, UK., Vicik SM; Pfizer, Walton Oaks, Surrey, UK., Hulesch BT; Brains and Cheek, London, UK. bors@brainsandcheek.com., McDonald LL; Brains and Cheek, London, UK.

Publikováno v: Rheumatology and therapy [Rheumatol Ther] 2020 Sep; Vol. 7 (3), pp. 537-552. Date of Electronic Publication: 2020 Jun 04.

Factors Affecting Patient Adherence to Inhalation Therapy: An Application of SEIPS Model 2.0.

Autor: Ma, Jing (AUTHOR), Sun, Xu (AUTHOR), Wang, Xinwei (AUTHOR), Liu, Bingjian (AUTHOR), Shi, Kaiqi (AUTHOR)

Publikováno v: Patient Preference & Adherence. Mar2023, Vol. 17, p531-545. 15p.

The Adherence and Outcomes Benefits of Using a Connected, Reusable Auto-Injector for Self-Injecting Biologics: A Narrative Review.

Autor: Antalfy, Attila, Berman, Kyle, Everitt, Claire, Alten, Rieke, Latymer, Mark, Godfrey, Charles M.

Publikováno v: Advances in Therapy; Nov2023, Vol. 40 Issue 11, p4758-4776, 19p

Bioequivalence Between a New Omalizumab Prefilled Syringe With an Autoinjector or with a Needle Safety Device Compared with the Current Prefilled Syringe: A Randomized Controlled Trial in Healthy Volunteers.

Autor: Sangana R; Novartis Institutes for Biomedical Research, Cambridge, MA, USA., Xu Y; Genentech Research and Early Development, South San Francisco, CA, USA., Shah B; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Tian X; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Zack J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Shakeri-Nejad K; Novartis Pharma AG, Basel, Switzerland., Kalluri S; Novartis Healthcare Pvt, Hyderabad, India., Jones I; Novartis Pharma AG, Basel, Switzerland., Ligueros-Saylan M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Taylor AF; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Jain DK; Novartis Pharma AG, Basel, Switzerland., Scosyrev E; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Uddin A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Laurent N; Novartis Pharma AG, Basel, Switzerland., Paganoni P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.

Publikováno v: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Jun; Vol. 13 (6), pp. 611-620. Date of Electronic Publication: 2024 Feb 22.